Some children with gender dysphoria recruited to a trial on puberty blockers could remain on the drugs after the study ends despite them being banned in the UK to treat under-18s with the condition, researchers have said.
Experts have launched a clinical trial looking at the impact of puberty blockers, with the first patients expected to be available for recruitment in the new year.
